Tate & Lyle Signs Contract Manufacturing Agreement with Amyris

| Filed in:

Tate & Lyle announces that it has entered into a contract manufacturing agreement with California based Amyris, Inc. Under this agreement, Tate & Lyle will produce farnesene at its facilities in Decatur, Illinois. The product will be owned and distributed by Amyris.

"We are delighted to be working with Amyris to help them achieve the first commercialization of its farnesene product," said Matt Wineinger, President, Bulk Ingredients, Tate & Lyle. "The combination of Tate & Lyle’s leading-edge facilities and expertise, and Amyris’ fermentation processes and equipment are a truly excellent fit.

"We are excited to be collaborating with Tate & Lyle to accelerate our commercial production of farnesene," said John Melo, CEO of Amyris. "Beyond supporting our commercial production targets in 2011, we believe that this partnership will allow us to leverage Tate & Lyle’s world leading expertise in aseptic fermentation operations as we ramp our industrial scale."

Click here for our press image gallery

About Tate & Lyle: 
Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, fortification, and texture, we develop ingredient solutions which reduce sugar, calories, and fat, add fibre and protein, and provide texture and stability in categories including beverages, dairy, bakery, snacks, soups, sauces, and dressings.

We have more than 3,500 employees working in around 57 locations across 39 countries. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives Through the Science of Food. By living our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2023, Tate & Lyle revenue from continuing operations totalled £1.75 billion. For more information, please visit https://www.tateandlyle.com or follow Tate & Lyle on LinkedinX (Twitter)Facebook or YouTube